ArticleFrontiers in immunology2025

Berberine-taxifolin co-administration attenuates inflammatory response and intestinal barrier injury via nf-κB/NLRP3 suppression in colitis.

Ganggang Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.